fbpx
  • NAVC Brands

Oncology

Fall 2018, Oncology

Chemotherapy-Induced Side Effects in Pets: Prevention and Treatment

Emily Fullerton RVT, VTS (Oncology) | VCA Veterinary Referral Associates | Gaithersburg, Maryland

Emily obtained her associate’s degree from Vet Tech Institute in December 2008, leading her to her registered veterinary technician license in January 2009. She subsequently moved to Maryland, where she found her place in veterinary medicine: medical oncology. With her passion for helping animals and support from her coworkers, she achieved her Veterinary Technician Specialist certification in oncology in 2014. Emily has a love of  food and wine, her own fuzzy pets, and spending time with her family.

Although the goal of chemotherapy in veterinary patients is to extend the life of the patient without the harsh side effects seen in human oncology patients, side effects still occur regardless of the precautions taken.

Summer 2018, Oncology

Clinical Progress of Lingual Hemangiosarcoma in a Cat

Sandra Farfan LVT Cornell University Veterinary Specialists, Stamford, CT

Sandra Farfan works in the oncology department at Cornell University Veterinary Specialists in Stamford, Connecticut. Born and raised in Bogota, Colombia, she became a veterinary nurse after moving to Connecticut in 2007. After earning her license in 2013, Sandra began her career in oncology at the Veterinary Cancer Center in Norwalk, Connecticut, as a nurse and nurse supervisor. She has presented case reports at the ACVIM Forum and Veterinary Cancer Society conferences. She is currently a VTS candidate (oncology).

This case report describes the symptoms, signs, diagnosis, and follow-up of a feline patient with an uncommon oral tumor. The favorable clinical outcome after single-agent doxorubicin chemotherapy and radiation showed that these modalities can be used to manage discomfort and tumor control, improving the quality of life of a patient with lingual hemangiosarcoma.

This article provides an overview of canine high-grade multicentric lymphoma and its classification, diagnosis, and treatment.
Sep/Oct 2017, Oncology

Canine Multicentric Lymphoma: An Overview

Kriste Sears-Sein RVT, VTS (Oncology) | University of California, Davis

Kriste has been working in the veterinary field in and around Sacramento, California, since 1997. After receiving her RVT in 1999, she began working in emergency and holistic medicine, which sparked her interest in the human–animal bond and quality-of-life focus in veterinary medicine. In 2008 she received her veterinary technician specialist certification in oncology, and since then has lectured around the United States on various topics related to cancer and compassionate care. She has been working as the Medical Oncology Supervisor at the University of California, Davis, since 2010.

This article provides an overview of canine high-grade multicentric lymphoma and its classification, diagnosis, and treatment.

Doxorubicin is one of the most dangerous chemotherapeutics used in veterinary oncology. However, it is also one of the most common and efficacious treatments for several types of canine and feline cancer. This article provides an overview of doxorubicin’s uses and precautions to take when administering it.
May/June 2017, Oncology

Doxorubicin: An Overview

Emily Fullerton RVT, VTS (Oncology) | VCA Veterinary Referral Associates | Gaithersburg, Maryland

Emily obtained her associate’s degree from Vet Tech Institute in December 2008, leading her to her registered veterinary technician license in January 2009. She subsequently moved to Maryland, where she found her place in veterinary medicine: medical oncology. With her passion for helping animals and support from her coworkers, she achieved her Veterinary Technician Specialist certification in oncology in 2014. Emily has a love of  food and wine, her own fuzzy pets, and spending time with her family.

Doxorubicin is one of the most dangerous chemotherapeutics used in veterinary oncology. However, it is also one of the most common and efficacious treatments for several types of canine and feline cancer. This article provides an overview of doxorubicin’s uses and precautions to take when administering it.

Zoobiquity: For Me, It’s Personal
March/April 2016, Diagnostics , Oncology

Zoobiquity: For Me, It’s Personal

Lynne Johnson-Harris LVT, RVT | Editor in Chief

Ms. Johnson-Harris has been involved with the NAVC as a speaker and moderator since 1990. She was the first veterinary technician to serve as an elected Board member of the NAVC serving the Board from 2003 to 2015. Ms Johnson-Harris was also the first veterinary technician to serve as the President of the NAVC (2013-2014). Along with being the Editor in Chief of Today’s Veterinary Nurse journal, Ms. Johnson-Harris is the NAVC Specialty Programs manager and works as the practice manager working along side her husband, Dr. Jerry Harris at Hinckley Animal Hospital.

In October 2014, my veterinarian husband noticed a swelling on the left side of our sweet, old golden retriever’s face. Maybe it’s nothing serious, we reassured ourselves as we proceeded with the diagnostics. The histopathology results were devastating. Emme had a malignant melanoma.

MENU